NCT02215798View on ClinicalTrials.gov

Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients

CompletedOBSERVATIONAL
Enrollment

269

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

October 31, 2009

Conditions
Pain
Interventions
DRUG

Cymbalta

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY